VERGANI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 6.420
AS - Asia 3.362
EU - Europa 2.693
SA - Sud America 528
Continente sconosciuto - Info sul continente non disponibili 331
AF - Africa 85
OC - Oceania 5
AN - Antartide 1
Totale 13.425
Nazione #
US - Stati Uniti d'America 6.124
SG - Singapore 1.323
IT - Italia 1.050
CN - Cina 693
VN - Vietnam 392
BR - Brasile 382
HK - Hong Kong 351
RU - Federazione Russa 349
DE - Germania 264
CA - Canada 210
SE - Svezia 201
GB - Regno Unito 159
IE - Irlanda 158
FR - Francia 115
IN - India 115
BD - Bangladesh 100
UA - Ucraina 80
ID - Indonesia 68
ES - Italia 54
NL - Olanda 53
AR - Argentina 49
TR - Turchia 46
AT - Austria 43
FI - Finlandia 43
IQ - Iraq 41
KR - Corea 41
MX - Messico 41
PL - Polonia 34
ZA - Sudafrica 34
EC - Ecuador 32
PK - Pakistan 31
JP - Giappone 25
PH - Filippine 23
BE - Belgio 17
CO - Colombia 17
UZ - Uzbekistan 17
DK - Danimarca 16
SA - Arabia Saudita 15
VE - Venezuela 14
CH - Svizzera 13
JM - Giamaica 12
JO - Giordania 12
NP - Nepal 11
AE - Emirati Arabi Uniti 9
KE - Kenya 9
MA - Marocco 9
CL - Cile 8
CR - Costa Rica 8
CZ - Repubblica Ceca 8
ET - Etiopia 8
LT - Lituania 8
TN - Tunisia 7
UY - Uruguay 7
IL - Israele 6
KZ - Kazakistan 6
MY - Malesia 6
OM - Oman 5
PE - Perù 5
PY - Paraguay 5
TH - Thailandia 5
AU - Australia 4
BO - Bolivia 4
CI - Costa d'Avorio 4
GR - Grecia 4
GT - Guatemala 4
NG - Nigeria 4
RO - Romania 4
AL - Albania 3
EG - Egitto 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
PS - Palestinian Territory 3
PT - Portogallo 3
SR - Suriname 3
AZ - Azerbaigian 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
GE - Georgia 2
GP - Guadalupe 2
GY - Guiana 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
EE - Estonia 1
Totale 13.082
Città #
Singapore 779
Ann Arbor 652
Ashburn 614
Milan 379
Fairfield 370
San Jose 362
Hong Kong 335
Dallas 317
Woodbridge 280
Houston 218
Wilmington 209
Chandler 201
New York 197
Frankfurt am Main 170
Seattle 151
Dublin 147
Los Angeles 147
Santa Clara 134
Toronto 132
Council Bluffs 123
Ho Chi Minh City 122
Beijing 120
Cambridge 120
Dearborn 110
Hanoi 86
Hefei 83
Chicago 80
Jacksonville 72
Rome 69
Princeton 66
São Paulo 61
Jakarta 57
Buffalo 49
Lauterbourg 46
Boardman 45
The Dalles 44
Columbus 43
Nanjing 43
Seoul 40
Orem 34
Montreal 33
Lawrence 31
Vienna 28
Denver 27
Turin 27
San Francisco 25
Warsaw 25
Phoenix 24
Atlanta 23
London 23
Moscow 23
Tokyo 23
Amsterdam 22
Pune 22
Besana In Brianza 21
Chennai 21
San Diego 21
Baghdad 20
Guangzhou 20
Johannesburg 20
Altamura 19
Brooklyn 19
Da Nang 19
Shanghai 19
Egg Harbor 17
Nanchang 17
Zhengzhou 17
Munich 16
Nuremberg 16
Quito 16
Brussels 15
Haiphong 15
Helsinki 15
Tashkent 14
Washington 14
Lahore 13
Rio de Janeiro 13
Salt Lake City 13
Stockholm 13
Andover 12
Boston 12
Brasília 12
Changsha 12
Mexico City 12
Ottawa 12
Bologna 11
Bắc Ninh 11
Cinisello Balsamo 11
Desio 11
Detroit 11
Figino 11
Lappeenranta 11
Melzo 11
Miami 11
Mumbai 11
Zurich 11
Hebei 10
Lachine 10
Naples 10
New Delhi 10
Totale 8.319
Nome #
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 600
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 388
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 384
Embryonic hematopoietic stem and progenitor cells show differential susceptibility to leukemic transformation upon acquisition of JMML-associated KrasG12D mutation 361
TNF-related apoptosis-inducing ligand (trail)-armed exosomes deliver proapoptotic signals to tumor site 348
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy 344
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 344
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors 336
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment 332
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: A case report 328
Null ABCA3 in humans: Large homozygous ABCA3 deletion, correlation to clinical-pathological findings 327
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b 307
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells 304
pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma 303
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 303
Evidence for a role of autoinflammation in early-phase psoriasis 303
ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling. 294
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6 292
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability 286
Complex immune contextures characterise malignant peritoneal mesothelioma: Loss of adaptive immunological signature in the more aggressive histological types 262
Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3 261
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators 255
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy 253
Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3d surrogate microenvironment 253
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 249
Miaquant, a novel system for automatic segmentation, measurement, and localization comparison of different biomarkers from serialized histological slices 247
Characterization of fast-twitch and slow-twitch skeletal muscles of calsequestrin 2 (CASQ2)-knock out mice: unexpected adaptive changes of fast-twitch muscles only 246
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class i peptides: Impact on the antigen-specific T cell response 242
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression 239
Pulmonary resections: Cytostructural effects of different-wavelength lasers versus electrocautery 230
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 227
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 226
A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sections 223
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis 220
Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro 213
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade 208
Monkeypox: A Histopathological and Transmission Electron Microscopy Study 200
Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome 200
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 198
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 197
Proposal of a classification of cannulation damage in vascular access grafts based on clinical, ultrasound, and microscopic observations 196
New Techniques:The Use of Fixed-Frozen Tissue in Routine Ultrastructural Evaluation and Immunogold Labeling 190
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors 185
Molecular abnormalities in liposarcoma: Role of MDM2 and CDK4-containing amplicons at 12q13-22 184
Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma 177
Morphologic-cytogenetic analysis of dedifferentiated liposarcomas with an extensive misleading leiomyosarcomatous component 176
Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis 175
Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer 169
Genetic surfactant dysfunction in newborn infants and children with acute and chronic lung disease 148
Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes? 145
Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model 112
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma 107
Embryonic hematopoietic stem and progenitor cells show differential susceptibility to leukemic transformation upon acquisition of JMML-associated KrasG12D mutation 64
Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome 64
Totale 13.425
Categoria #
all - tutte 43.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022337 0 0 63 19 26 22 16 31 24 29 47 60
2022/2023820 74 212 83 91 33 121 39 39 64 11 35 18
2023/2024701 35 56 16 28 83 201 92 23 51 5 16 95
2024/20251.957 98 211 168 105 215 126 56 69 243 267 135 264
2025/20266.131 582 379 587 559 622 292 768 261 437 519 656 469
2026/2027560 158 236 166 0 0 0 0 0 0 0 0 0
Totale 13.425